MAPT and Alzheimer disease: On the other hand, when tau phosphorylation is inhibited, insoluble tau load and neurodegeneration are attenuated in vivo6, further implicating phosphorylation as a possible mechanism for the pathogenesis and progression of AD and other tauopathies.